Literature DB >> 4054760

Risk factors for the increased seizure frequency during pregnancy and puerperium.

K Otani.   

Abstract

Possible factors affecting the seizure frequency during pregnancy and puerperium were prospectively studied on 125 cases, paying particular attention to the drug compliance and the antiepileptic drug disposition. Of the subjects, 27% were under the poor compliance category. As the reasons for the poor compliance, anxiety about the side effects of antiepileptic drugs including teratogenecity and the harmful effects on their newborns by breast feeding were found in about half of them. In the cases with regular drug taking, 80% showed no change in the seizure frequency whereas only 16% exhibited an increase and 4% a decrease. The apparent serum clearance of phenytoin, primidone, phenobarbitone derived from primidone and valproic acid increased during pregnancy and puerperium. In some cases, the lowering of the serum level of drugs was associated with the aggravation of seizures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054760     DOI: 10.1111/j.1440-1819.1985.tb01942.x

Source DB:  PubMed          Journal:  Folia Psychiatr Neurol Jpn        ISSN: 0015-5721


  9 in total

Review 1.  Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?

Authors:  Naghme Adab
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  The Effect of Epilepsy on Sleep Quality During Pregnancy and Postpartum.

Authors:  Sheela Toprani; Kimford J Meador; Chelsea P Robalino; Carrie Anne Brown; Abigail G Matthews; Elizabeth E Gerard; Patricia Penovich; Evan Gedzelman; Jennifer Cavitt; Sean T Hwang; Laura A Kalayjian; Maria Sam; Alison Pack; Page B Pennell
Journal:  Neurology       Date:  2022-07-19       Impact factor: 11.800

Review 3.  Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Authors:  Kristina M Deligiannidis; Nancy Byatt; Marlene P Freeman
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

Review 4.  Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.

Authors:  L Bertilsson; T Tomson
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 5.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; J Hopp; T Y Ting; P B Pennell; J A French; W A Hauser; S Wiebe; G S Gronseth; D Thurman; K J Meador; B S Koppel; P W Kaplan; J N Robinson; B Gidal; C A Hovinga; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

Review 6.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

Authors:  P B Pennell; L Peng; D J Newport; J C Ritchie; A Koganti; D K Holley; M Newman; Z N Stowe
Journal:  Neurology       Date:  2007-11-28       Impact factor: 9.910

8.  Refractory status epilepticus spontaneously resolved by parturition.

Authors:  Hye Seon Jeong; Eung Seok Oh; Ji Hee Lee; Jae Moon Kim
Journal:  J Epilepsy Res       Date:  2011-03-30

Review 9.  Pregnancy and the Control of Epileptic Seizures: A Review.

Authors:  Mervyn J Eadie
Journal:  Neurol Ther       Date:  2021-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.